Study guide
3.3 Control of Breathing, Hypoxia, Altitude and Hyperbaric Physiology
EDAIC Part I European Diploma in Anaesthesiology and Intensive Care
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: The EDAIC Part I Examination
1.1 EDAIC Part I Exam Format, Scoring and Multiple True/False Strategy
2 Chapter 2: Anatomy for Anaesthesia and Intensive Care
2.1 Functional Anatomy of the Upper Airway, Larynx, and Tracheobronchial Tree 2.2 Neuraxial Anatomy: Spine, Spinal Cord, Meninges, and Spaces 2.3 Vascular Anatomy for Central and Peripheral Cannulation 2.4 Peripheral Nerve Plexuses and Autonomic Nervous System Pathways 2.5 Thoracic Anatomy: Chest Wall, Intercostal Spaces, Pleura, Mediastinum and Heart
3 Chapter 3: Respiratory and Cardiovascular Physiology
3.1 Respiratory Mechanics, Lung Volumes, and Work of Breathing 3.2 Ventilation-Perfusion Relationships, Shunt, and Gas Exchange 3.3 Control of Breathing, Hypoxia, Altitude and Hyperbaric Physiology 3.4 Cardiac Cycle, Electrophysiology, and Ventricular Function 3.5 Vascular Resistance, Microcirculation, and Systemic Hemodynamics
4 Chapter 4: Neurophysiology, Renal, Hepatic and Acid-Base Physiology
4.1 Cerebral Blood Flow, Intracranial Pressure, and CSF Dynamics 4.2 Renal Physiology, Glomerular Filtration, and Tubular Transport 4.3 Hepatic Blood Flow, Metabolism, and Clearance 4.4 Acid-Base Regulation, Buffering Systems, and Stewart Approach
5 Chapter 5: Endocrine and Haematological Physiology
5.1 Endocrine Physiology and the Neuroendocrine Stress Response 5.2 Haemostasis Physiology, Coagulation Testing and Inherited Bleeding Disorders
6 Chapter 6: Special Patient Physiology: Maternal, Paediatric and Geriatric
6.1 Maternal Physiological Adaptations to Pregnancy and Uteroplacental Flow 6.2 Neonatal and Paediatric Physiological Differences 6.3 Physiological Changes of Ageing and Thermoregulation
7 Chapter 7: General Pharmacological Principles and Inhalational Anaesthetics
7.1 Pharmacokinetic Principles, Compartmental Models, and Clearance 7.2 Pharmacodynamic Mechanisms, Receptor Theory, and Drug Interactions 7.3 Physical Properties, Uptake, and Distribution of Volatile Anaesthetics 7.4 Minimum Alveolar Concentration (MAC), Organ Effects, and Toxicity
8 Chapter 8: Intravenous Agents, Neuromuscular Blockade and Analgesics
8.1 Intravenous Induction Agents: Propofol, Etomidate, Ketamine, and Barbiturates 8.2 Neuromuscular Blocking Agents: Depolarizing and Non-Depolarizing Drugs 8.3 Neuromuscular Monitoring and Reversal: Anticholinesterases and Sugammadex 8.4 Opioid Pharmacology, Receptors, and Non-Opioid Analgesic Agents
9 Chapter 9: Cardiovascular Drugs, Autonomic Pharmacology and Local Anaesthetics
9.1 Inotropes, Vasopressors, and Inodilators in Perioperative Care 9.2 Antiarrhythmic, Antihypertensive, and Beta-Adrenergic Antagonist Drugs 9.3 Local Anaesthetic Pharmacology, Toxicity (LAST), and Lipid Emulsion Therapy
10 Chapter 10: Haematological and Internal Medicine Pharmacology
10.1 Anticoagulant, Antiplatelet and Haemostatic Drugs and Their Reversal 10.2 Internal Medicine Drugs: Endocrine, Respiratory, Psychiatric and Antiepileptic Agents and Their Anaesthetic Interactions
11 Chapter 11: Physics, Clinical Measurement and Medical Equipment
11.1 Physical Gas Laws, Fluid Dynamics, and Resistance Principles 11.2 Anaesthetic Machines, Gas Supply Pipelines, Cylinders, and Safety Mechanisms 11.3 Breathing Systems, Vaporizer Mechanics, and Scavenging Systems 11.4 Invasive and Non-Invasive Hemodynamic and Respiratory Monitoring
12 Chapter 12: Electrical Safety, Temperature, Humidity and Gas Analysis
12.1 Electricity, Electrical Safety, Diathermy, Defibrillation, Implanted Devices and Fire 12.2 Temperature Measurement, Humidity, Gas Analysis and SI Units
13 Chapter 13: Biostatistics, Clinical Trials and Evidence Appraisal
13.1 Descriptive Statistics, Distributions, and Parametric vs Non-Parametric Tests 13.2 Hypothesis Testing, Power, Type I/II Errors, and Confidence Intervals 13.3 Clinical Study Designs, Bias, and Diagnostic Test Performance (Sensitivity, Specificity, ROC)
14 Chapter 14: General Anaesthesia, Preoperative Evaluation and Airway Management
14.1 Preoperative Risk Assessment, Cardiovascular Risk Indices, and Fasting Guidelines 14.2 The Difficult Airway: Assessment, Algorithms, and Rescue Oxygenation 14.3 Intraoperative Fluid Therapy, Goal-Directed Hemodynamics, and Blood Conservation 14.4 Post-Anaesthesia Care Unit (PACU) Management, Emergence, and Postoperative Nausea/Vomiting
15 Chapter 15: Coexisting Disease and Preoperative Investigations
15.1 Interpreting Investigations: ECG, Chest Radiograph, Lung Function and Blood Tests 15.2 Coexisting Disease I: Asthma, COPD, Obstructive Sleep Apnoea, Obesity, Liver and Renal Disease 15.3 Endocrine Disease and Emergencies: Diabetes, DKA and HHS, Thyroid, Adrenal, Phaeochromocytoma and Carcinoid 15.4 Coexisting Disease II: Neuromuscular and Neurological Disease
16 Chapter 16: Subspecialty Anaesthesia: Cardiothoracic, Vascular and Neuroanaesthesia
16.1 Anaesthesia for Cardiac Surgery and Cardiopulmonary Bypass Management 16.2 Thoracic Anaesthesia, One-Lung Ventilation, and Major Vascular Surgery 16.3 Neuroanaesthesia: Craniotomy, Sitting Position, and Traumatic Brain Injury
17 Chapter 17: Obstetric, Paediatric and Ambulatory Anaesthesia
17.1 Obstetric Analgesia and Anaesthesia: Labour, Caesarean Delivery, and High-Risk Conditions 17.2 Paediatric Anaesthesia: Induction, Airway Management, and Emergencies 17.3 Ambulatory Day-Surgery Selection, Premedication, and Elderly Patient Anaesthesia
18 Chapter 18: Anaesthetic Complications and Specialty Settings
18.1 Anaesthetic Complications: Accidental Awareness, Aspiration, Positioning Injuries, Visual Loss and Dental Damage 18.2 Anaesthesia for ENT and Laser Airway Surgery, Ophthalmic Surgery, and Laparoscopic and Robotic Surgery
19 Chapter 19: Regional Anaesthesia and Acute/Chronic Pain Management
19.1 Neuraxial Techniques: Spinal, Epidural, and Caudal Anaesthesia 19.2 Upper and Lower Limb Peripheral Nerve and Fascial Plane Blocks 19.3 Multimodal Acute Postoperative Pain Management and ERAS Pathways 19.4 Chronic and Neuropathic Pain Syndromes and Interventional Management 19.5 Palliative Symptom Control, Psychological Aspects of Pain and Multidisciplinary Pain Management
20 Chapter 20: Intensive Care Medicine: Ventilation, Shock and Organ Support
20.1 Acute Respiratory Distress Syndrome (ARDS) and Mechanical Ventilation Strategies 20.2 Sepsis-3 Definitions, Septic Shock, and Hemodynamic Resuscitation 20.3 Acute Kidney Injury, Indications for Dialysis, and Continuous Renal Replacement Therapy 20.4 ICU Sedation, Delirium, Weaning, and Brain Death Determination
21 Chapter 21: Intensive Care Medicine: Admission, Nutrition, Infection and Electrolytes
21.1 ICU Admission, Severity Scoring, Nutrition and Routine Prophylaxis 21.2 Antimicrobial Therapy, Stewardship and ICU-Acquired Infections 21.3 Electrolyte Disorders: Sodium, Potassium, Calcium, Magnesium and Phosphate
22 Chapter 22: Intensive Care and Emergency Medicine: Neurocritical Care, Poisoning and Cardiorespiratory Emergencies
22.1 Neurocritical Care: Subarachnoid Haemorrhage, Stroke, Status Epilepticus and Acute Neuromuscular Failure 22.2 Acute Poisoning: Toxidromes, Decontamination and Specific Antidotes 22.3 Acute Cardiorespiratory Emergencies: Pulmonary Embolism, Acute Severe Asthma and COPD, Non-Invasive Support and Acute Heart Failure
23 Chapter 23: Resuscitation, Perioperative Emergencies and Professional Ethics
23.1 Advanced Life Support (ALS) Guidelines and Perioperative Cardiac Arrest 23.2 Perioperative Crises: Malignant Hyperthermia and Severe Anaphylaxis 23.3 Major Trauma, Hemorrhagic Shock, and Massive Transfusion Protocols 23.4 Professional Ethics, Informed Consent, Patient Safety, and Helsinki Declaration
24 Chapter 24: Newborn, Paediatric and Obstetric Emergencies
24.1 Newborn Life Support and Paediatric Life Support 24.2 Obstetric Emergencies: Maternal Collapse, Amniotic Fluid Embolism, Uterine Inversion and Resuscitative Hysterotomy
25 Chapter 25: Burns, Environmental Emergencies and Patient Transport
25.1 Burns, Inhalation Injury, Drowning, Hypothermia, Heat Illness and Decompression Illness 25.2 Prehospital Care and Intra- and Inter-Hospital Transport of the Critically Ill
3.3 Control of Breathing, Hypoxia, Altitude and Hyperbaric Physiology
Key Takeaways Explain This Topic AI
Central chemoreceptors on the ventral medulla respond to the pH of cerebrospinal fluid, which follows arterial P a CO 2 P_a\text{CO}_2 P a CO 2 , and generate about 70-80% of the resting ventilatory drive.
The carotid bodies are the main peripheral chemoreceptors; they respond rapidly to a fall in P a O 2 P_a\text{O}_2 P a O 2 below about 8 kPa (60 mmHg), to acidaemia and to hypercapnia, and signal through the glossopharyngeal nerve.
Volatile anaesthetics depress the hypoxic ventilatory response even at sub-anaesthetic concentrations of about 0.1 MAC, and opioids shift the carbon dioxide response curve to the right and flatten it.
At high altitude the inspired oxygen partial pressure falls with barometric pressure; hyperventilation, raised erythropoietin and increased 2,3-diphosphoglycerate form the main acclimatisation responses.
Hyperbaric oxygen at 2.4-3.0 atmospheres absolute raises dissolved oxygen to about 5-6 mL/dL and is used for carbon monoxide poisoning, decompression illness and arterial gas embolism.
Last updated: October 2026
- 3.3 Control of Breathing, Hypoxia, Altitude and Hyperbaric Physiology
- The Respiratory Control System
- Breathing is controlled by a feedback loop with three parts: SENSORS CONTROLLER EFFECTORS
- Central chemoreceptors --> Medullary respiratory --> Diaphragm (phrenic C3-C5)
- Peripheral chemoreceptors centres (dorsal and Intercostal muscles
- Lung stretch / J receptors ventral respiratory Accessory muscles
- Cortex (voluntary), pain groups, pre-Botzinger Upper airway dilators
- complex); pons modulates
The pre-Botzinger complex in the ventral medulla generates the basic respiratory rhythm.
The dorsal respiratory group (nucleus tractus solitarius) integrates afferent input from the glossopharyngeal and vagus nerves.
The pontine respiratory group fine-tunes the transition between inspiration and expiration.
Cortical control allows voluntary breath-holding and hyperventilation, and is lost during sleep and anaesthesia, when chemical control dominates.
Central Chemoreceptors and the Carbon Dioxide Response
The central chemoreceptors lie near the ventral surface of the medulla. They respond to the hydrogen ion concentration of the surrounding cerebrospinal fluid (CSF). Carbon dioxide crosses the blood-brain barrier freely, but hydrogen and bicarbonate ions cross slowly, so CSF pH tracks arterial P a CO 2 P_a\text{CO}_2 P a CO 2 closely. Because CSF contains little protein, its buffering capacity is low, which makes it a sensitive detector.
In awake adults, minute ventilation rises roughly linearly by about 2-3 L/min for each 1 mmHg (about 15-20 L/min per kPa) increase in P a CO 2 P_a\text{CO}_2 P a CO 2 above the resting value.
The central chemoreceptors provide about 70-80% of the response to carbon dioxide.
In chronic hypercapnia, CSF bicarbonate rises over days and resets the receptors, so the drive to breathe from carbon dioxide is reduced.
Effects of Drugs on the Carbon Dioxide Response
Agent Effect on the CO 2 \text{CO}_2 CO 2 response curve
Opioids Shift to the right and reduce the slope; raise the apnoeic threshold; reduce respiratory rate more than tidal volume
- Volatile anaesthetics Dose-dependent reduction in slope; rapid shallow breathing
- Benzodiazepines Modest depression alone, but synergistic with opioids
Acidaemia, hypoxia, salicylates Shift to the left (more ventilation at any P a CO 2 P_a\text{CO}_2 P a CO 2 )
Peripheral Chemoreceptors and the Hypoxic Response
The carotid bodies at the carotid bifurcation, supplied by the glossopharyngeal nerve (carotid sinus nerve), are the most important peripheral chemoreceptors; the aortic bodies (vagus nerve) contribute mainly to circulatory reflexes. Carotid body type I (glomus) cells have an extremely high blood flow relative to their metabolism, so they sense arterial partial pressure of oxygen, not oxygen content. Anaemia and carbon monoxide poisoning therefore do not stimulate them strongly.
The hypoxic ventilatory response is hyperbolic : ventilation changes little until P a O 2 P_a\text{O}_2 P a O 2 falls below about 8 kPa (60 mmHg) , then rises steeply.
The carotid bodies respond within seconds and also respond to acidaemia and hypercapnia, contributing about 20-30% of the carbon dioxide response.
Volatile anaesthetics depress the acute hypoxic ventilatory response even at about 0.1 MAC , so residual anaesthetic in recovery can blunt the reaction to hypoxaemia.
Bilateral carotid endarterectomy can abolish the hypoxic drive.
Types of Hypoxia
- Type Mechanism Example P a O 2 P_a\text{O}_2 P a O 2 Arterial oxygen content
- Hypoxaemic Low arterial oxygen tension Altitude, hypoventilation, shunt, V/Q mismatch Low Low
- Anaemic Low functional haemoglobin Anaemia, carbon monoxide poisoning Normal Low
- Stagnant (circulatory) Low blood flow Cardiogenic shock, tourniquet Normal Normal, but delivery falls
- Histotoxic Cells cannot use oxygen Cyanide poisoning Normal Normal; venous oxygen high
Remember oxygen delivery: D ˙ O 2 = C O × C a O 2 \dot{D}\text{O}_2 = CO \times C_a\text{O}_2 D ˙ O 2 = CO × C a O 2 , where C a O 2 = ( 1.34 × Hb × S a O 2 ) + ( 0.023 × P a O 2 ) C_a\text{O}_2 = (1.34 \times \text{Hb} \times S_a\text{O}_2) + (0.023 \times P_a\text{O}_2) C a O 2 = ( 1.34 × Hb × S a O 2 ) + ( 0.023 × P a O 2 ) with haemoglobin in g/dL and P a O 2 P_a\text{O}_2 P a O 2 in kPa.
High-Altitude Physiology
Barometric pressure falls roughly exponentially with altitude, halving at about 5,500 m. The fraction of oxygen remains 0.21, but the inspired partial pressure falls:
P I O 2 = 0.21 × ( P B − 6.3 kPa ) P_I\text{O}_2 = 0.21 \times (P_B - 6.3\text{ kPa}) P I O 2 = 0.21 × ( P B − 6.3 kPa )
At sea level ( P B P_B P B 101.3 kPa), P I O 2 P_I\text{O}_2 P I O 2 is about 19.9 kPa. On the summit of Everest ( P B P_B P B about 33.7 kPa) it is only about 5.8 kPa.
Acute and Chronic Responses
Hyperventilation from carotid body stimulation lowers P A CO 2 P_A\text{CO}_2 P A CO 2 and raises P A O 2 P_A\text{O}_2 P A O 2 , but causes respiratory alkalosis that initially limits the response.
Renal compensation over 2-3 days excretes bicarbonate and lets ventilation rise further. Acetazolamide speeds this process.
Erythropoietin rises within hours; haemoglobin increases over weeks.
2,3-Diphosphoglycerate increases, shifting the oxygen dissociation curve to the right, although the respiratory alkalosis shifts it to the left.
Hypoxic pulmonary vasoconstriction raises pulmonary artery pressure.
Altitude Illnesses
Acute mountain sickness: headache, nausea and fatigue after ascent above about 2,500 m.
High-altitude cerebral oedema: ataxia and confusion; requires descent, oxygen and dexamethasone.
High-altitude pulmonary oedema: non-cardiogenic oedema from uneven hypoxic pulmonary vasoconstriction; treat with descent, oxygen and nifedipine.
Vaporizers at altitude: a variable-bypass vaporizer delivers an almost constant partial pressure of agent, so its clinical effect is largely unchanged, whereas the heated desflurane vaporizer delivers a constant volume percentage, so the partial pressure falls and the dial setting must be increased.
Hyperbaric Physiology
Pressure increases by about 1 atmosphere (101.3 kPa) for every 10 m of seawater . Under hyperbaric conditions:
Boyle's law governs gas-filled spaces: volume halves at 2 atmospheres absolute (ATA), causing barotrauma to ears, sinuses and lungs during pressure changes.
Dissolved oxygen rises with partial pressure (Henry's law). Breathing 100% oxygen at 3 ATA gives a P a O 2 P_a\text{O}_2 P a O 2 of about 250-280 kPa and about 6 mL/dL of dissolved oxygen, which is enough to meet resting tissue needs without haemoglobin.
Nitrogen narcosis occurs when breathing air at depth, typically below about 30 m.
Oxygen toxicity: central nervous system toxicity (seizures) at high partial pressures, and pulmonary toxicity with prolonged exposure.
Indications for Hyperbaric Oxygen
- Accepted indication Rationale
- Decompression illness Shrinks bubbles and speeds nitrogen elimination
- Arterial gas embolism Reduces bubble size and improves tissue oxygenation
Severe carbon monoxide poisoning Shortens the carboxyhaemoglobin half-life from about 4-5 hours in air to about 20 minutes at 2.5-3 ATA
Necrotising soft tissue infection, radiation tissue injury, problem wounds Adjunct to surgery and antibiotics
Anaesthetic implications in a chamber: untreated pneumothorax is an absolute contraindication (a chest drain must be placed); air in endotracheal tube cuffs and infusion devices contracts during compression, so cuffs are filled with saline; defibrillation and electrical equipment carry a fire risk in an oxygen-enriched atmosphere.